Results 61 to 70 of about 54,214 (96)

Sleep apnoea, hypertension and vascular disease: where are we now?

European Respiratory Review, 2007
The objective of the present article was to explore the relationship between obstructive sleep apnoea (OSA) and hypertension (HT) and/or arterial vascular disease (VD), including stroke and ischaemic coronary disease.
B. Buyse, J. Hedner, The participants of working group 2   +2 more
doaj  

Spectrophotometry of (32) Pomona, (145) Adeona, (704) Interamnia, (779) Nina, (330825) 2008 XE3, and 2012 QG42 and laboratory study of possible analog samples [PDF]

, 2015
V. Busarev, S. Barabanov, V. Rusakov, V. Puzin, V. Kravtsov   +4 more
semanticscholar   +1 more source

Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients

Respiratory Research, 2023
Stefania Lo Cicero, Germana Castelli, Giovanna Blaconà, Sabina Maria Bruno, Giovanni Sette, Riccardo Pigliucci, Valeria Rachela Villella, Speranza Esposito, Immacolata Zollo, Francesca Spadaro, Ruggero De Maria, Mauro Biffoni, Giuseppe Cimino, Felice Amato, Marco Lucarelli, Adriana Eramo   +15 more
doaj   +1 more source

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma.

Journal of Clinical Oncology, 2004
M. Atkins, M. Hidalgo, W. Stadler, T. Logan, J. Dutcher, G. Hudes, Young Park, S. Liou, Bonnie Marshall, J. Boni, G. Dukart, M. Sherman   +11 more
semanticscholar   +1 more source

Retraction Note: Shp2 positively regulates cigarette smoke-induced epithelial mesenchymal transition by mediating MMP-9 production

Respiratory Research, 2023
Ya-nan Liu, Yan Guan, Jian Shen, Yong-liang Jia, Jian-cang Zhou, Yun Sun, Jun-xia Jiang, Hui-juan Shen, Qiang Shu, Qiang-min Xie, Yicheng Xie   +10 more
doaj   +1 more source

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.

Journal of Clinical Oncology, 2005
E. Galanis, J. Buckner, M. Maurer, J. Kreisberg, K. Ballman, J. Boni, J. Peralba, R. Jenkins, S. Dakhil, R. Morton, K. Jaeckle, B. Scheithauer, J. Dancey, M. Hidalgo, D. J. Walsh   +14 more
semanticscholar   +1 more source

Posttransplant Major Histocompatibility Complex Class I Chain-Related Gene A Antibodies and Long-Term Graft Outcomes in a Multicenter Cohort of 779 Kidney Transplant Recipients

Transplantation, 2012
Anne Lemy, M. Andrien, A. Lionet, M. Labalette, C. Noel, C. Hiesse, M. Delahousse, C. Suberbielle-Boissel, M. De Meyer, D. Latinne, M. Mourad, Séverine Delsaut, J. Racapé, K. Wissing, M. Toungouz, D. Abramowicz   +15 more
semanticscholar   +1 more source

Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer.

Journal of Clinical Oncology, 2004
E. Raymond, J. Alexandre, S. Faivre, K. Vera, E. Materman, J. Boni, C. Leister, J. Korth-Bradley, A. Hanauske, J. Armand   +9 more
semanticscholar   +1 more source

Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.

Journal of Clinical Oncology, 2005
S. Chan, M. Scheulen, S. Johnston, K. Mross, F. Cardoso, C. Dittrich, W. Eiermann, D. Hess, R. Morant, V. Semiglazov, M. Borner, M. Salzberg, V. Ostapenko, H. Illiger, D. Behringer, N. Bardy-Bouxin, J. Boni, S. Kong, M. Cincotta, L. Moore   +19 more
semanticscholar   +1 more source

Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein.

Journal of Clinical Oncology, 2011
C. Hofmeister, Xiaoxia Yang, F. Pichiorri, Ping Chen, Darlene M. Rozewski, A. Johnson, Seungsoo Lee, Zhongfa Liu, C. Garr, E. Hade, Jia Ji, L. Schaaf, D. Benson, E. Kraut, W. Hicks, K. Chan, Ching S. Chen, S. Farag, M. Grever, J. Byrd, M. Phelps   +20 more
semanticscholar   +1 more source